practice · Tracked item
Checkpoint inhibitor immunotherapy
Every recorded take from the experts Cited tracks — each with the exact quote, source, and timestamp.
-
William LiEndorsesBe Well by Kelly Leveque
Dr. Li describes checkpoint inhibitor immunotherapy (e.g., Keytruda, Opdivo) as a breakthrough cancer treatment that unleashes immune defenses against tumors.
“Keytruda and Opdivo
BW▶ 48:40DosageInfusion every 3 weeksCaveatsOnly ~20% of patients respond optimallyCertaintyexplicitstrong endorsement